Health
New gene therapy restores dystrophin protein in patients with Duchenne muscular dystrophy – News-Medical.Net
UT Southwestern scientists successfully employed a new type of gene therapy to treat mice with Duchenne muscular dystrophy (DMD), uniquely utilizing CRISPR-Cas9-based…
UT Southwestern scientists successfully employed a new type of gene therapy to treat mice with Duchenne muscular dystrophy (DMD), uniquely utilizing CRISPR-Cas9-based tools to restore a large section of the dystrophin protein that is missing in many DMD patients.
The approach, described online today in the journal Science Advances, could lead to a treatment for DMD and inform the treatment of other inherited diseases.
Thousands of different mutations causing Duchenne have been identified, but they…
-
Noosa News21 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News19 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General24 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News22 hours agoStar Entertainment faces $36.5m blow if Queen’s Wharf deal flops